Barclays begins covering AmSurg stock — 4 points

Barclays has begun coverage on shares of AmSurg, according to a Corvus Business report.

Advertisement

Here are four points:

1.  The brokerage issued an equal weight rating and an $85 price objective on the stock.

2. The stock’s 50-day moving average is $79.60 and its 200-day moving average is $77.75.

3. AmSurg stock has a 12-month low of $52.42 and a 12-month high of $87.42.

4. The stock has a market capitalization of $3.43 billion.

More articles on ASC issues:
Surgery Partners moves to new office location: 4 notes
5 things to know about using Twitter to assess patient perspective on medical errors
7 key trends in healthcare spending for 2016

Advertisement

Next Up in ASC News

Advertisement

Comments are closed.